Insight Molecular Diagnostics Inc.
IMDX
$3.41
$0.041.19%
NASDAQ
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -75.77% | 43.88% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -75.77% | 43.88% | |||
| Cost of Revenue | -79.16% | -7.25% | |||
| Gross Profit | -73.72% | 115.88% | |||
| SG&A Expenses | -4.95% | 14.89% | |||
| Depreciation & Amortization | -- | -68.18% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -5.25% | 15.43% | |||
| Operating Income | -20.58% | -7.63% | |||
| Income Before Tax | -46.04% | 80.09% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -46.04% | 80.09% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -46.04% | 80.09% | |||
| EBIT | -20.58% | -7.63% | |||
| EBITDA | -21.19% | -10.00% | |||
| EPS Basic | -17.18% | 86.53% | |||
| Normalized Basic EPS | 2.52% | 27.20% | |||
| EPS Diluted | -17.18% | 86.53% | |||
| Normalized Diluted EPS | 2.52% | 27.20% | |||
| Average Basic Shares Outstanding | 24.63% | 47.82% | |||
| Average Diluted Shares Outstanding | 24.63% | 47.82% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||